Trade Law Daily is a Warren News publication.

ITC Receives Section 337 Complaint on Dermatological Treatment Devices

Comments are due March 16 regarding a potential International Trade Commission investigation on imported dermatological treatment devices, a Federal Register notice said (ITC docket no. 3670). The notice follows a March 1 complaint by Serendia, which alleged that 15 named respondents import and sell products that infringe six of Serendia's patents. The patents concern methods and items for treating skin tissue using bipolar electrodes in portable devices. Serendia has asked the ITC for a permanent limited exclusion order barring from entry all infringing devices and components manufactured or imported by the respondents or their affiliates along with cease-and-desist orders. The named respondents are:

Sign up for a free preview to unlock the rest of this article

Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.

  • Sung Hwan E&B
  • Aesthetics Biomedical
  • Cartessa Aesthetics
  • Lutronic
  • Lutronic Aesthetics
  • Lutronic, LLC
  • Ilooda
  • Cutera
  • Jeisys Medical
  • Cynosure
  • Rohrer Aesthetics, LLC
  • Rohrer Aesthetics, Inc.
  • EndyMed Medical
  • EndyMed Medical, Ltd.
  • EndyMed Medical Inc.